The aims of this study were to evaluate the anti-inflammatory effects of EVs derived from kefir grain Lactobacillus, PRCC-1301 EVs, on the experimental murine colitis model and cell lines, and its association with the NF-κB pathway and intestinal barrier function. This evidence concerns the gene NFKB1 and colitis.